Nitinol Thrombectomy Stent Industry Research Report 2025

Summary

According to APO Research, the global Nitinol Thrombectomy Stent market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Nitinol Thrombectomy Stent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nitinol Thrombectomy Stent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Nitinol Thrombectomy Stent is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Nitinol Thrombectomy Stent include Acandis GmbH, Balt Group, Furukawa Techno Material, Johnson & Johnson MedTech, Penumbra, Rapid Medical, Stryker, Guichuangtongqiao Medical and Hemu Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nitinol Thrombectomy Stent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitinol Thrombectomy Stent.

The report will help the Nitinol Thrombectomy Stent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Nitinol Thrombectomy Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nitinol Thrombectomy Stent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Nitinol Thrombectomy Stent Segment by Company

Acandis GmbH
Balt Group
Furukawa Techno Material
Johnson & Johnson MedTech
Penumbra
Rapid Medical
Stryker
Guichuangtongqiao Medical
Hemu Biotech
Jianshi Medical
Medtronic
Sinoshenchang Medical
Suzhou Zhongtian Medical
Micro-Port Shentong Medical
Xinkainuo Medical
Xinwei Medical
Nitinol Thrombectomy Stent Segment by Type

Diameter 3MM
Diameter 4MM
Diameter 6MM
Other
Nitinol Thrombectomy Stent Segment by Application

Hospital
Clinic
Other
Nitinol Thrombectomy Stent Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers


High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nitinol Thrombectomy Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nitinol Thrombectomy Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nitinol Thrombectomy Stent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nitinol Thrombectomy Stent manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nitinol Thrombectomy Stent by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nitinol Thrombectomy Stent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Nitinol Thrombectomy Stent Market Size (2020-2031)
2.2.2 Global Nitinol Thrombectomy Stent Sales (2020-2031)
2.2.3 Global Nitinol Thrombectomy Stent Market Average Price (2020-2031)
2.3 Nitinol Thrombectomy Stent by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Diameter 3MM
2.3.3 Diameter 4MM
2.3.4 Diameter 6MM
2.3.5 Other
2.4 Nitinol Thrombectomy Stent by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Hospital
2.4.3 Clinic
2.4.4 Other
3 Market Competitive Landscape by Manufacturers
3.1 Global Nitinol Thrombectomy Stent Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Nitinol Thrombectomy Stent Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Nitinol Thrombectomy Stent Revenue of Manufacturers (2020-2025)
3.4 Global Nitinol Thrombectomy Stent Average Price by Manufacturers (2020-2025)
3.5 Global Nitinol Thrombectomy Stent Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Nitinol Thrombectomy Stent, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Nitinol Thrombectomy Stent, Product Type & Application
3.8 Global Manufacturers of Nitinol Thrombectomy Stent, Established Date
3.9 Global Nitinol Thrombectomy Stent Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Acandis GmbH
4.1.1 Acandis GmbH Company Information
4.1.2 Acandis GmbH Business Overview
4.1.3 Acandis GmbH Nitinol Thrombectomy Stent Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Acandis GmbH Nitinol Thrombectomy Stent Product Portfolio
4.1.5 Acandis GmbH Recent Developments
4.2 Balt Group
4.2.1 Balt Group Company Information
4.2.2 Balt Group Business Overview
4.2.3 Balt Group Nitinol Thrombectomy Stent Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Balt Group Nitinol Thrombectomy Stent Product Portfolio
4.2.5 Balt Group Recent Developments
4.3 Furukawa Techno Material
4.3.1 Furukawa Techno Material Company Information
4.3.2 Furukawa Techno Material Business Overview
4.3.3 Furukawa Techno Material Nitinol Thrombectomy Stent Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Furukawa Techno Material Nitinol Thrombectomy Stent Product Portfolio
4.3.5 Furukawa Techno Material Recent Developments
4.4 Johnson & Johnson MedTech
4.4.1 Johnson & Johnson MedTech Company Information
4.4.2 Johnson & Johnson MedTech Business Overview
4.4.3 Johnson & Johnson MedTech Nitinol Thrombectomy Stent Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Johnson & Johnson MedTech Nitinol Thrombectomy Stent Product Portfolio
4.4.5 Johnson & Johnson MedTech Recent Developments
4.5 Penumbra
4.5.1 Penumbra Company Information
4.5.2 Penumbra Business Overview
4.5.3 Penumbra Nitinol Thrombectomy Stent Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Penumbra Nitinol Thrombectomy Stent Product Portfolio
4.5.5 Penumbra Recent Developments
4.6 Rapid Medical
4.6.1 Rapid Medical Company Information
4.6.2 Rapid Medical Business Overview
4.6.3 Rapid Medical Nitinol Thrombectomy Stent Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Rapid Medical Nitinol Thrombectomy Stent Product Portfolio
4.6.5 Rapid Medical Recent Developments
4.7 Stryker
4.7.1 Stryker Company Information
4.7.2 Stryker Business Overview
4.7.3 Stryker Nitinol Thrombectomy Stent Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Stryker Nitinol Thrombectomy Stent Product Portfolio
4.7.5 Stryker Recent Developments
4.8 Guichuangtongqiao Medical
4.8.1 Guichuangtongqiao Medical Company Information
4.8.2 Guichuangtongqiao Medical Business Overview
4.8.3 Guichuangtongqiao Medical Nitinol Thrombectomy Stent Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Guichuangtongqiao Medical Nitinol Thrombectomy Stent Product Portfolio
4.8.5 Guichuangtongqiao Medical Recent Developments
4.9 Hemu Biotech
4.9.1 Hemu Biotech Company Information
4.9.2 Hemu Biotech Business Overview
4.9.3 Hemu Biotech Nitinol Thrombectomy Stent Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Hemu Biotech Nitinol Thrombectomy Stent Product Portfolio
4.9.5 Hemu Biotech Recent Developments
4.10 Jianshi Medical
4.10.1 Jianshi Medical Company Information
4.10.2 Jianshi Medical Business Overview
4.10.3 Jianshi Medical Nitinol Thrombectomy Stent Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Jianshi Medical Nitinol Thrombectomy Stent Product Portfolio
4.10.5 Jianshi Medical Recent Developments
4.11 Medtronic
4.11.1 Medtronic Company Information
4.11.2 Medtronic Business Overview
4.11.3 Medtronic Nitinol Thrombectomy Stent Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Medtronic Nitinol Thrombectomy Stent Product Portfolio
4.11.5 Medtronic Recent Developments
4.12 Sinoshenchang Medical
4.12.1 Sinoshenchang Medical Company Information
4.12.2 Sinoshenchang Medical Business Overview
4.12.3 Sinoshenchang Medical Nitinol Thrombectomy Stent Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Sinoshenchang Medical Nitinol Thrombectomy Stent Product Portfolio
4.12.5 Sinoshenchang Medical Recent Developments
4.13 Suzhou Zhongtian Medical
4.13.1 Suzhou Zhongtian Medical Company Information
4.13.2 Suzhou Zhongtian Medical Business Overview
4.13.3 Suzhou Zhongtian Medical Nitinol Thrombectomy Stent Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Suzhou Zhongtian Medical Nitinol Thrombectomy Stent Product Portfolio
4.13.5 Suzhou Zhongtian Medical Recent Developments
4.14 Micro-Port Shentong Medical
4.14.1 Micro-Port Shentong Medical Company Information
4.14.2 Micro-Port Shentong Medical Business Overview
4.14.3 Micro-Port Shentong Medical Nitinol Thrombectomy Stent Sales, Revenue and Gross Margin (2020-2025)
4.14.4 Micro-Port Shentong Medical Nitinol Thrombectomy Stent Product Portfolio
4.14.5 Micro-Port Shentong Medical Recent Developments
4.15 Xinkainuo Medical
4.15.1 Xinkainuo Medical Company Information
4.15.2 Xinkainuo Medical Business Overview
4.15.3 Xinkainuo Medical Nitinol Thrombectomy Stent Sales, Revenue and Gross Margin (2020-2025)
4.15.4 Xinkainuo Medical Nitinol Thrombectomy Stent Product Portfolio
4.15.5 Xinkainuo Medical Recent Developments
4.16 Xinwei Medical
4.16.1 Xinwei Medical Company Information
4.16.2 Xinwei Medical Business Overview
4.16.3 Xinwei Medical Nitinol Thrombectomy Stent Sales, Revenue and Gross Margin (2020-2025)
4.16.4 Xinwei Medical Nitinol Thrombectomy Stent Product Portfolio
4.16.5 Xinwei Medical Recent Developments
5 Global Nitinol Thrombectomy Stent Market Scenario by Region
5.1 Global Nitinol Thrombectomy Stent Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Nitinol Thrombectomy Stent Sales by Region: 2020-2031
5.2.1 Global Nitinol Thrombectomy Stent Sales by Region: 2020-2025
5.2.2 Global Nitinol Thrombectomy Stent Sales by Region: 2026-2031
5.3 Global Nitinol Thrombectomy Stent Revenue by Region: 2020-2031
5.3.1 Global Nitinol Thrombectomy Stent Revenue by Region: 2020-2025
5.3.2 Global Nitinol Thrombectomy Stent Revenue by Region: 2026-2031
5.4 North America Nitinol Thrombectomy Stent Market Facts & Figures by Country
5.4.1 North America Nitinol Thrombectomy Stent Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Nitinol Thrombectomy Stent Sales by Country (2020-2031)
5.4.3 North America Nitinol Thrombectomy Stent Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Nitinol Thrombectomy Stent Market Facts & Figures by Country
5.5.1 Europe Nitinol Thrombectomy Stent Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Nitinol Thrombectomy Stent Sales by Country (2020-2031)
5.5.3 Europe Nitinol Thrombectomy Stent Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Nitinol Thrombectomy Stent Market Facts & Figures by Country
5.6.1 Asia Pacific Nitinol Thrombectomy Stent Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Nitinol Thrombectomy Stent Sales by Country (2020-2031)
5.6.3 Asia Pacific Nitinol Thrombectomy Stent Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Nitinol Thrombectomy Stent Market Facts & Figures by Country
5.7.1 South America Nitinol Thrombectomy Stent Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Nitinol Thrombectomy Stent Sales by Country (2020-2031)
5.7.3 South America Nitinol Thrombectomy Stent Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Nitinol Thrombectomy Stent Market Facts & Figures by Country
5.8.1 Middle East and Africa Nitinol Thrombectomy Stent Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Nitinol Thrombectomy Stent Sales by Country (2020-2031)
5.8.3 Middle East and Africa Nitinol Thrombectomy Stent Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Nitinol Thrombectomy Stent Sales by Type (2020-2031)
6.1.1 Global Nitinol Thrombectomy Stent Sales by Type (2020-2031) & (K Units)
6.1.2 Global Nitinol Thrombectomy Stent Sales Market Share by Type (2020-2031)
6.2 Global Nitinol Thrombectomy Stent Revenue by Type (2020-2031)
6.2.1 Global Nitinol Thrombectomy Stent Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Nitinol Thrombectomy Stent Revenue Market Share by Type (2020-2031)
6.3 Global Nitinol Thrombectomy Stent Price by Type (2020-2031)
7 Segment by Application
7.1 Global Nitinol Thrombectomy Stent Sales by Application (2020-2031)
7.1.1 Global Nitinol Thrombectomy Stent Sales by Application (2020-2031) & (K Units)
7.1.2 Global Nitinol Thrombectomy Stent Sales Market Share by Application (2020-2031)
7.2 Global Nitinol Thrombectomy Stent Revenue by Application (2020-2031)
7.2.1 Global Nitinol Thrombectomy Stent Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Nitinol Thrombectomy Stent Revenue Market Share by Application (2020-2031)
7.3 Global Nitinol Thrombectomy Stent Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Nitinol Thrombectomy Stent Value Chain Analysis
8.1.1 Nitinol Thrombectomy Stent Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Nitinol Thrombectomy Stent Production Mode & Process
8.2 Nitinol Thrombectomy Stent Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Nitinol Thrombectomy Stent Distributors
8.2.3 Nitinol Thrombectomy Stent Customers
9 Global Nitinol Thrombectomy Stent Analyzing Market Dynamics
9.1 Nitinol Thrombectomy Stent Industry Trends
9.2 Nitinol Thrombectomy Stent Industry Drivers
9.3 Nitinol Thrombectomy Stent Industry Opportunities and Challenges
9.4 Nitinol Thrombectomy Stent Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings